Regulators Must Keep Pace with Advancement of AI for Fresh and Innovative Healthcare Benefits

In this contributed article, Elaine Gemmell, Head of Regulatory Affairs at InnoScot Health, discusses regulators needing to keep pace with advancement of artificial intelligence for fresh and innovative healthcare benefits.

New Study Puts Claude3 and GPT-4 up Against a Medical Knowledge Pressure Test

Kahun, the evidence-based clinical AI engine for healthcare providers, shares the findings from a new study on the medical capabilities of readily-available large language models (LLMs). The study compared the medical accuracy of OpenAI’s GPT-4 and Anthropic’s Claude3-Opus to each other and human medical experts through questions based on objective medical knowledge drawn from Kahun’s Knowledge Graph.

In AI We Don’t Trust: Too Many Healthcare Insurers Base Decisions on Assumption Over Data, Report Reveals

The healthcare insurance sector in the US is struggling to make critical decisions due to a severe lack of accessibility, context and trust in their data. That is according to a new international study by ActiveOps, a leading provider of AI-powered decision intelligence for service operations.

The Transformative Role of AI in the Healthcare Industry

In this feature article, Daniel D. Gutierrez, insideAInews Editor-in-Chief & Resident Data Scientist, discusses how the integration of AI into healthcare systems promises to enhance patient care, streamline clinical operations, and foster innovative research, marking a significant shift in how medical services are delivered and experienced.

How Can Data Science Accelerate Drug Discovery Processes?

In this contributed article, April Miller, senior IT and cybersecurity writer for ReHack Magazine, describes how thoughtfully applied data science principles and tools empower modern researchers to find new, viable treatment methods for various diseases and ailments. Humans will always be essential to drug discoveries, but the fascinating examples here and elsewhere show the power of using purposeful data analytics to meet shared goals. 

Where Artificial Intelligence Is Making a Difference in Healthcare

In this contributed article, Rajesh Viswanathan, Chief Technology Officer for Inovalon, discusses how for the past year, AI was at the center of conversations throughout healthcare. While the potential for AI to revolutionize healthcare is clear, from care delivery to enhancing operational efficiencies and accelerating research, many organizations are still figuring out where to begin.

Quantum-Enhanced Generative AI Generates Viable Cancer Drug Candidates

Zapata Computing, Inc., the Industrial Generative AI company, announced that its scientists, in collaboration with Insilico Medicine, the University of Toronto, and St. Jude Children’s Research Hospital have demonstrated the first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates. The research points to a promising future of hybrid quantum generative AI for drug discovery using today’s quantum devices.

Using Clinician Big Data to Alleviate a Struggling Workforce

In this contributed article, Charlie Lougheed, CEO and co-founder of Axuall, explains why healthcare needs to adjust its thinking and in what ways clinician big data can make impactful changes throughout the healthcare industry, from credentialing to attrition.

The Future of Applied AI in 2024: Transforming Healthcare, Energy, and Supply Chain with Tangible Outcomes

In this contribute article, Nick King, CEO and Founder of Data Kinetic, believes that 2024 holds great promise for Applied AI as it integrates into various sectors, transforming manufacturing, healthcare, energy, and beyond. However, as we move forward in this AI-driven future, addressing concerns such as misleading marketing, complex interactions, the need for guardrails and transparency, and the importance of meaningful AI education is crucial.

Survey: Generative AI Shaking Up Digital Health Investors’ Funding Strategies and Industry Outlooks

Digital health investors say generative AI, oncology care and the challenges posed by clinician shortages are transforming their startup funding strategies and investment outlooks for the healthcare industry, according to the results of an online survey from GSR Ventures. Startup company valuation expectations among backers, however, are significantly lower than in 2022.